Oxford vaccine phase 3 trials resume after halt over safety concerns
First Published: 12th September, 2020 22:03 IST
The third phase of AstraZeneca’s coronavirus vaccine have resumed in the UK, days after they were halted over safety concerns. AstraZeneca said on Saturday that it received confirmation from the
The third phase of AstraZeneca’s coronavirus vaccine have resumed in the UK, days after they were halted over safety concerns.
AstraZeneca said on Saturday that it received confirmation from the United Kingdom’s Medicines Health Regulatory Authority that it was safe to resume clinical trials, CNBC reported.
AstraZeneca, a UK-based biopharma giant, had announced on Tuesday that the phase 3 testing of its COVID-19 vaccine being developed by it with Oxford University has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom.
The company said that that the “standard review process triggered a voluntary pause” to all global trials on September 6 so that independent committees and internal regulators could review the safety data.
“Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so,” Astra Zeneca said in a statement.
While trials can now resume in the UK, the status of trials elsewhere remains unclear.
“The company will continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic,” the statement said.
The University of Oxford, which developed the vaccine in partnership with AstraZeneca, said on Saturday that some 18,000 people have so far received the vaccination in trials.
“In large trials such as this, it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety,” it said in a statement. (ANI)
COMMENTS
TOPMOST STORY NOW
Live Brother of BSF Jawan Deepak Chingakham Who Died in Cross-Border Firing by Pakistan in Jammu Appointed ASI in Manipur Police on Compassionate Grounds
11th July 2025
Live Maikhuli Villagers Protest MoU Over Assam-Meghalaya Border, Demand Return of Fishery
11th July 2025
Live Chhangur Baba Received Rs 500 Crore in Foreign Funds for Illegal Conversions: Anti-Terror Squad
11th July 2025
Live Taiwan Detects 9 Chinese Warships, 1 Aircraft Breaching ADIZ Amid Rising Tensions
11th July 2025
WE RECOMMEND
Space Menu Goes Desi: Gajar Ka Halwa Wins Over International Astronauts
The sweet surprise, specially developed for space consumption by ISRO and DRDO, was the centrepiece of a lively gathering aboard Axiom Mission 4.
11th July 2025
“Show Me One Photo of Collateral Damage in OP Sindoor, Operation precise to the point,” NSA, Ajit Doval Dares Foreign Media
National Security Advisor, Ajit Doval on Friday dismissed foreign media reports of collateral damage in India during Operation Sindoor. Hailing Operation Sindoor as a proud moment for India, Doval challenged critics to produce even a single image of destruction of Indian property. Speaking at the 62nd Convocation of IIT Madras, Doval said “Show me even […]
11th July 2025
From Moradabad to Apple HQ: Meet Sabih Khan, the New COO of the iPhone Giant
At Apple, he steadily climbed the ranks and most recently served as the Senior Vice President of Operations.
11th July 2025
Axiom-4 crew, including Group Captain Shubhanshu Shukla, scheduled to undock from ISS on July 14
Axiom Mission 4 was launched on June 25 aboard a SpaceX Falcon 9 rocket from Launch Complex 39A
11th July 2025
Trump announces 35 per cent tariffs on goods imported from Canada
Trump threatened to increase the tariff rate by the same amount if Canada decides to increase their tariffs on importing American products.
11th July 2025